BR112014026308A2 - composições de cultura celular e métodos para produção de polipeptídeos - Google Patents

composições de cultura celular e métodos para produção de polipeptídeos

Info

Publication number
BR112014026308A2
BR112014026308A2 BR112014026308A BR112014026308A BR112014026308A2 BR 112014026308 A2 BR112014026308 A2 BR 112014026308A2 BR 112014026308 A BR112014026308 A BR 112014026308A BR 112014026308 A BR112014026308 A BR 112014026308A BR 112014026308 A2 BR112014026308 A2 BR 112014026308A2
Authority
BR
Brazil
Prior art keywords
cell culture
methods
compositions
media
polypeptides
Prior art date
Application number
BR112014026308A
Other languages
English (en)
Other versions
BR112014026308A8 (pt
Inventor
Zhang Boyan
Gawlitzek Martin
S Mun Melissa
Vijayasankaran Natarajan
Varma Sharat
R Arevalo Silvana
J Meier Steven
Carvalhal Veronica
Yang Yi
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49380652&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014026308(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BR112014026308A2 publication Critical patent/BR112014026308A2/pt
Publication of BR112014026308A8 publication Critical patent/BR112014026308A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

abstract cell culture media, such as chemically defined cell culture media, are provided, as are methods of using the media for cell growth (i.e., cell culture) and polypeptide (e.g., antibody) production. compositions comprising polypeptides produced by the methods are also provided. tradução do resumo resumo patente de invenção: “composições de cultura celular e métodos para produção de polipeptídeos”. a presente invenção se refere a meios de cultura celular, tais como meios de cultura celular quimicamente definidos, assim como se refere a métodos de utilização dos meios para crescimento celular (isto é, cultura celular) e produção de polipeptídeos (por exemplo, anticorpos). além disso a presente invenção se refere a composições compreendendo polipeptídeos produzidos pelos métodos.
BR112014026308A 2012-04-24 2013-04-24 meios de cultura celular, seu método de cultura, polipeptídeo, seu método de produção e seu uso, composições farmacêutica, e kit BR112014026308A8 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261637778P 2012-04-24 2012-04-24
US201261637780P 2012-04-24 2012-04-24
US13/841,864 US20130281355A1 (en) 2012-04-24 2013-03-15 Cell culture compositions and methods for polypeptide production
PCT/US2013/037992 WO2013163294A1 (en) 2012-04-24 2013-04-24 Cell culture compositions and methods for polypeptide production

Publications (2)

Publication Number Publication Date
BR112014026308A2 true BR112014026308A2 (pt) 2017-06-27
BR112014026308A8 BR112014026308A8 (pt) 2021-06-01

Family

ID=49380652

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014026308A BR112014026308A8 (pt) 2012-04-24 2013-04-24 meios de cultura celular, seu método de cultura, polipeptídeo, seu método de produção e seu uso, composições farmacêutica, e kit

Country Status (22)

Country Link
US (2) US20130281355A1 (pt)
EP (2) EP3533864A1 (pt)
JP (4) JP6367792B2 (pt)
KR (2) KR102115052B1 (pt)
CN (2) CN104428409A (pt)
AR (1) AR090822A1 (pt)
AU (2) AU2013251647B2 (pt)
BR (1) BR112014026308A8 (pt)
CA (1) CA2871006C (pt)
ES (1) ES2716301T3 (pt)
HK (1) HK1208496A1 (pt)
HR (1) HRP20190484T1 (pt)
IL (1) IL235235A0 (pt)
MX (2) MX363493B (pt)
MY (1) MY181513A (pt)
NZ (1) NZ701791A (pt)
PL (1) PL2841561T3 (pt)
RU (2) RU2678142C2 (pt)
SG (2) SG10201810830UA (pt)
SI (1) SI2841561T1 (pt)
WO (1) WO2013163294A1 (pt)
ZA (2) ZA201408092B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
KR102202476B1 (ko) * 2013-03-15 2021-01-12 제넨테크, 인크. 세포 배양 배지 및 항체 생산 방법
RU2718986C2 (ru) * 2013-03-15 2020-04-15 Дженентек, Инк. Композиции клеточных культур с антиоксидантами и способы получения полипептидов
EP3052640A2 (en) * 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
WO2018229802A1 (en) * 2017-06-16 2018-12-20 Ge Healthcare Bio-Sciences Ab Method for predicting outcome of and modelling of a process in a bioreactor
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
CN108823267B (zh) * 2018-06-25 2020-05-08 深圳市菲鹏生物制药股份有限公司 调节cho-k1表达系统所分泌抗体的酸性峰含量的方法
EP4051790A4 (en) * 2019-10-31 2023-11-01 William Marsh Rice University GENETICALLY ENGINEERED CELLS FOR CONTROLLED PRODUCTION
TW202128744A (zh) 2019-12-06 2021-08-01 美商再生元醫藥公司 抗ｖｅｇｆ蛋白組合物及其製備方法
CA3163829A1 (en) 2020-01-31 2021-08-05 Takahiro Matsuo Method for producing composition containing polypeptide with suppressed coloring
JP7404929B2 (ja) 2020-02-26 2023-12-26 富士フイルムビジネスイノベーション株式会社 発光装置、光学装置及び計測装置
JP7404930B2 (ja) 2020-02-26 2023-12-26 富士フイルムビジネスイノベーション株式会社 発光装置、光学装置及び計測装置
GB202012991D0 (en) 2020-08-20 2020-10-07 Ucb Biopharma Sprl Cell culture processes
IL303951A (en) * 2020-12-22 2023-08-01 Novartis Ag Methods for reducing the oxidation level of cysteine residues in recombinantly secreted protein during cell culture
GB202105424D0 (en) 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
CA3229424A1 (en) 2021-09-02 2023-03-09 Boehringer Ingelheim International Gmbh Method of determining a future color value or corresponding property and arrangement therefor
WO2023063611A1 (ko) * 2021-10-12 2023-04-20 프레스티지바이오로직스 주식회사 항체 집단의 제조 방법

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
JPS5863385A (ja) 1981-10-02 1983-04-15 ハナ・バイオロジツクス・インコ−ポレ−テツド 免疫系由来の細胞用培地
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4816401A (en) 1985-09-09 1989-03-28 University Of Rochester Serum free cell culture medium
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US6048728A (en) 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
JPH03180176A (ja) * 1989-11-16 1991-08-06 W R Grace & Co 細胞培養のための基礎栄養培地
WO1991008291A2 (en) 1989-11-22 1991-06-13 Genentech, Inc. Latency associated peptide and uses therefor
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
DK1136556T3 (da) 1991-11-25 2005-10-03 Enzon Inc Fremgangsmåde til fremstilling af multivalente antigen-bindende proteiner
JPH07102147B2 (ja) * 1992-03-16 1995-11-08 株式会社ミドリ十字 ヒト血清アルブミンの着色抑制方法
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5512477A (en) 1994-04-21 1996-04-30 Genzyme Corporation Serum-free medium supplement
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
EP0802257B1 (fr) * 1996-04-19 2002-08-21 Societe Des Produits Nestle S.A. Lignée immortalisée de cellules épithéliales du colon humain
US6103529A (en) * 1996-10-10 2000-08-15 Life Technologies, Inc. Animal cell culture media comprising peptides derived from rice
US20020012991A1 (en) 1997-04-07 2002-01-31 Florence Chua Nee Ho Kit Fong Cell culture media for enhanced protein production
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US6160099A (en) * 1998-11-24 2000-12-12 Jonak; Zdenka Ludmila Anti-human αv β3 and αv β5 antibodies
US20060286668A1 (en) 1999-04-30 2006-12-21 Invitrogen Corporation Animal-cell culture media comprising non-animal or plant-derived nutrients
WO2002066603A2 (en) 2001-02-15 2002-08-29 Centocor, Inc. Chemically defined medium for cultured mammalian cells
AU2002316230A1 (en) 2001-06-13 2002-12-23 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
AR047392A1 (es) 2002-10-22 2006-01-18 Wyeth Corp Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
GB0304799D0 (en) * 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
US7871607B2 (en) 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
CA2542125A1 (en) * 2003-10-09 2005-04-21 Kyowa Hakko Kogyo Co., Ltd. Process for producing antibody composition by using rna inhibiting the function of .alpha.1,6-fucosyltransferase
TWI384069B (zh) * 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
JP2008518597A (ja) * 2004-10-29 2008-06-05 セントカー・インコーポレーテツド 化学的規定培地組成物
CN100569940C (zh) * 2006-08-16 2009-12-16 华东理工大学 人胚胎肾(hek)293细胞无血清培养基
TW201516149A (zh) * 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
CN101553504A (zh) 2006-12-11 2009-10-07 豪夫迈·罗氏有限公司 Aβ抗体胃肠外制剂
JP4851543B2 (ja) * 2007-01-12 2012-01-11 日本板硝子株式会社 三次元細胞培養担体およびそれを用いた細胞培養方法
KR101022032B1 (ko) * 2007-07-20 2011-03-16 동국대학교 산학협력단 중간엽 줄기세포를 이용하여 모유두 조직을 제조하는 방법
JP5570989B2 (ja) * 2007-08-31 2014-08-13 アムジエン・インコーポレーテツド 固体タンパク質製剤
WO2009129379A1 (en) * 2008-04-17 2009-10-22 Wyeth Methods for enhanced production of bone morphogenetic proteins
CN102224239A (zh) * 2008-09-26 2011-10-19 先灵公司 高效价抗体生产
JO3672B1 (ar) * 2008-12-15 2020-08-27 Regeneron Pharma أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
US9540426B2 (en) * 2009-10-06 2017-01-10 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
ES2533074T3 (es) 2010-04-26 2015-04-07 Novartis Ag Medio de cultivo celular mejorado

Also Published As

Publication number Publication date
RU2018146497A (ru) 2019-02-04
SG11201406903SA (en) 2014-12-30
BR112014026308A8 (pt) 2021-06-01
MX363493B (es) 2019-03-26
AU2019202259A1 (en) 2019-04-18
EP2841561B1 (en) 2019-01-16
AU2013251647A1 (en) 2014-12-18
KR102115052B1 (ko) 2020-05-25
EP2841561A1 (en) 2015-03-04
US20130281355A1 (en) 2013-10-24
ES2716301T3 (es) 2019-06-11
RU2014147018A (ru) 2016-06-10
SI2841561T1 (sl) 2019-04-30
AU2019202259B2 (en) 2021-11-11
EP3533864A1 (en) 2019-09-04
CA2871006C (en) 2021-05-25
PL2841561T3 (pl) 2019-05-31
JP6367792B2 (ja) 2018-08-01
CN111440758A (zh) 2020-07-24
ZA201707452B (en) 2021-03-31
AR090822A1 (es) 2014-12-10
SG10201810830UA (en) 2018-12-28
IL235235A0 (en) 2014-12-31
WO2013163294A1 (en) 2013-10-31
HRP20190484T1 (hr) 2019-05-17
JP2023156371A (ja) 2023-10-24
ZA201408092B (en) 2019-03-27
MY181513A (en) 2020-12-24
HK1208496A1 (en) 2016-03-04
JP2015515281A (ja) 2015-05-28
KR20200057795A (ko) 2020-05-26
MX2014012838A (es) 2015-10-22
RU2678142C2 (ru) 2019-01-23
AU2013251647B2 (en) 2019-04-04
JP2021104023A (ja) 2021-07-26
CN104428409A (zh) 2015-03-18
MX2019003427A (es) 2020-11-12
KR102339106B1 (ko) 2021-12-15
US20240093143A1 (en) 2024-03-21
JP7323272B2 (ja) 2023-08-08
KR20150003351A (ko) 2015-01-08
CA2871006A1 (en) 2013-10-31
JP2018183154A (ja) 2018-11-22
NZ701791A (en) 2017-03-31

Similar Documents

Publication Publication Date Title
BR112014026308A2 (pt) composições de cultura celular e métodos para produção de polipeptídeos
SG10201805291TA (en) Production of heterodimeric proteins
MX2018014043A (es) Composiciones de cultivo celular con antioxidantes y metodos para la produccion de polipeptidos.
NZ630568A (en) Methods and means for the production of ch3 domain-comprising molecules
SG10201900948PA (en) Modified nucleotide linkers
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
MX366112B (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
UY34333A (es) ?métodos y composiciones para el control de malezas, y métodos para reducir la expresión de enzima dhps?
MX342034B (es) Proteinas monovalentes que se unen a antigenos.
EA201491418A1 (ru) Рекомбинантные микроорганизмы и способы их применения
EA201590550A1 (ru) Композиции и способы получения гликопротеинов
EA201391389A1 (ru) Кристаллы антител против склеростина и составы на их основе
UA111827C2 (uk) Спосіб отримання інгенол-3-ангелату
MX2020001357A (es) Produccion microbiana de aminas grasas.
GB201203085D0 (en) Hydrogels
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
EA201690793A1 (ru) Способ получения лиофилизированной фармацевтической композиции, содержащей митомицин c
FI20115328A (fi) Uusia kutinaaseja, niiden tuottaminen ja käytöt
MX2011012623A (es) Construcciones de casb7439.
DOP2015000007A (es) Métodos para preparar triazolopiridinas sutituidas
IN2014DN09097A (pt)
EA200900984A1 (ru) Улучшение клеточного роста
BR112021024852A2 (pt) Métodos de cultura de célula e composições para produção de anticorpo
EA201300884A1 (ru) Способ получения нового антибактериального лекарственного средства на основе рекомбинантного полипептида
FI20105694A0 (fi) Indusoidut proteiinit

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.